Total Funding
70
Total FundingGrant raised
Growth Score in past quarter
pts
Heat Score 70 in past quarter
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Bleeding-edge drug discovery for neurological disorders.
- David Booth: COO
- Michelle McGuinness: Head or Regulatory StrategyPast Role: Veloxis, VP, Global Regulatory Affairs & QA
About the Company
Expesicor was focused on discovering treatments for Epilepsy and neurodegenerative disorders.
